Abstract: A hemostatic applicator adapted to stop a bleeding site from bleeding is provided. The hemostatic applicator includes a magnetic part, an anti-adhesion layer and a non-magnetic part. The magnetic part is suitable to be heated to a temperature with a high frequency electromagnetic field. The anti-adhesion layer is formed on a surface of the magnetic part, and the magnetic part contacts the bleeding site through the anti-adhesion layer. The non-magnetic part is connected with the magnetic part. A hemostatic module is also provided.

Abstract: An electromagnetic thermotherapeutic apparatus includes a tubular needle and an inner needle. The tubular needle has an electromagnetic inductive portion that is made from a material capable of generating heat when subjected to an induction magnetic field, and that has a hollow tip, and a non-electromagnetic inductive portion that is connected to the electromagnetic inductive portion oppositely of the hollow tip. The inner needle is removably insertable into the tubular needle from the non-electromagnetic inductive portion to the hollow tip.

Abstract: An electromagnetic thermotherapeutic system is adapted to treat a biological tissue and includes an electromagnetic thermotherapeutic apparatus and a high frequency induction heating circuit unit. The apparatus includes a needle assembly and a temperature monitor. The needle assembly is adapted to be inserted in the biological tissue, and includes a flexible and bendable needle seat, and a plurality of ferrous needles that are attached to the needle seat and that have needle tips extending in a direction away from the needle seat. The temperature monitor is connected to the needle assembly. The high frequency induction heating circuit unit has an induction coil capable of producing an electromagnetic field to induce currents in the ferrous needles and to thereby heat the ferrous needles.

Abstract: An air filtering device for protection suits includes a case in which a fan unit is received and a filtering unit is engaged with a hole in a wall of the case and located outside of the case. A duct of the fan unit extends through a top of the case and is in communication with a muffler connected on the top of the case. A hose is connected with an aperture of the muffler. The fan unit can be driven by AC or DC power and the noise from the fan unit can be reduced by the muffler.

Abstract: An air filtering device for protection suits includes a case in which a fan unit is received and a filtering unit is engaged with a hole in a wall of the case and located outside of the case. A duct of the fan unit extends through a top of the case and is in communication with a muffler connected on the top of the case. A hose is connected with an aperture of the muffler. The fan unit can be driven by AC or DC power and the noise from the fan unit can be reduced by the muffler.

Abstract: A thermo-sensitve copolymer of following formula; is disclosed; wherein R1 is hydrogen, or —C(?O)—R2; R2 is C7-30 alkyl substituted or unsubstituted with functional groups; R3 is hydrogen, or C1-6 alkyl; and x, y or z individually is an integer greater than 0. The thermo-sensitive copolymers disclosed here are easy to be implanted into a human body through injection. The biodegradability is greatly improved and the cytotoxicity of the copolymers is low.

Abstract: A thermo-sensitve copolymer of following formula; is disclosed; wherein R1 is hydrogen, or —C(?O)—R2; R2 is C7-30 alkyl substituted or unsubstituted with functional groups; R3 is hydrogen, or C1-6 alkyl; and x, y or z individually is an integer greater than 0. The thermo-sensitive copolymers disclosed here are easy to be implanted into a human body through injection. The biodegradability is greatly improved and the cytotoxicity of the copolymers is low.

Abstract: The present invention relates to a temperature-sensitive thermogelling emulsion system for bioactive substances, consisting of a biodegradable temperature-sensitive aqueous phase polymer solution, and a pharmaceutically acceptable oil phase carrier, which embeds the bioactive substance. The oil phase carrier and the temperature-sensitive polymer solution are mixed mutually to produce the emulsion, and the emulsion is a liquid while the temperature is below the lower critical solution temperature (LCST) and reversibly transforms into a gel while the temperature is above said lower critical solution temperature. The emulsions are able to offer the controlled release without burst effect and afterward in a near zero order manner, as well as be non-invasively monitored post-implantation. The design of entrapment of the bioactive substances in the oily phase is also beneficial to preserve the bioactivity of the environment-sensitive substances.